These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 18068893)
21. A novel black tea pigment and two new oxidation products of epigallocatechin-3-O-gallate. Tanaka T; Matsuo Y; Kouno I J Agric Food Chem; 2005 Sep; 53(19):7571-8. PubMed ID: 16159188 [TBL] [Abstract][Full Text] [Related]
22. Structural Properties of Green Tea Catechins. Botten D; Fugallo G; Fraternali F; Molteni C J Phys Chem B; 2015 Oct; 119(40):12860-7. PubMed ID: 26369298 [TBL] [Abstract][Full Text] [Related]
23. Multifunctional effects of green tea catechins on prevention of the metabolic syndrome. Ikeda I Asia Pac J Clin Nutr; 2008; 17 Suppl 1():273-4. PubMed ID: 18296354 [TBL] [Abstract][Full Text] [Related]
24. Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzenesulfonyl (Ns) protecting group. Aihara Y; Yoshida A; Furuta T; Wakimoto T; Akizawa T; Konishi M; Kan T Bioorg Med Chem Lett; 2009 Aug; 19(15):4171-4. PubMed ID: 19524436 [TBL] [Abstract][Full Text] [Related]
25. Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation. Ishii T; Mori T; Tanaka T; Mizuno D; Yamaji R; Kumazawa S; Nakayama T; Akagawa M Free Radic Biol Med; 2008 Nov; 45(10):1384-94. PubMed ID: 18771724 [TBL] [Abstract][Full Text] [Related]
26. Antiplatelet activity of epigallocatechin gallate is mediated by the inhibition of PLCgamma2 phosphorylation, elevation of PGD2 production, and maintaining calcium-ATPase activity. Jin YR; Im JH; Park ES; Cho MR; Han XH; Lee JJ; Lim Y; Kim TJ; Yun YP J Cardiovasc Pharmacol; 2008 Jan; 51(1):45-54. PubMed ID: 18209568 [TBL] [Abstract][Full Text] [Related]
27. (-)-Epicatechin gallate accumulates in foamy macrophages in human atherosclerotic aorta: implication in the anti-atherosclerotic actions of tea catechins. Kawai Y; Tanaka H; Murota K; Naito M; Terao J Biochem Biophys Res Commun; 2008 Sep; 374(3):527-32. PubMed ID: 18657514 [TBL] [Abstract][Full Text] [Related]
28. Catechin prodrugs and analogs: a new array of chemical entities with improved pharmacological and pharmacokinetic properties. Bansal S; Vyas S; Bhattacharya S; Sharma M Nat Prod Rep; 2013 Oct; 30(11):1438-54. PubMed ID: 24056761 [TBL] [Abstract][Full Text] [Related]
29. Biotransformation of green tea polyphenols and the biological activities of those metabolites. Lambert JD; Sang S; Yang CS Mol Pharm; 2007; 4(6):819-25. PubMed ID: 17963356 [TBL] [Abstract][Full Text] [Related]
30. Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis. Sharma SK; Kumar G; Kapoor M; Surolia A Biochem Biophys Res Commun; 2008 Mar; 368(1):12-7. PubMed ID: 17996734 [TBL] [Abstract][Full Text] [Related]
31. Antioxidative activity of (-)-epigallocatechin-3-(3''-O-methyl)gallate isolated from fresh tea leaf and preliminary results on its biological activity. Kawase M; Wang R; Shiomi T; Saijo R; Yagi K Biosci Biotechnol Biochem; 2000 Oct; 64(10):2218-20. PubMed ID: 11129598 [TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability. Wang Y; Zhang H; Holmgren A; Tian W; Zhong L Oncol Rep; 2008 Dec; 20(6):1479-87. PubMed ID: 19020731 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of lipoxygenase by (-)-epigallocatechin gallate: X-ray analysis at 2.1 A reveals degradation of EGCG and shows soybean LOX-3 complex with EGC instead. Skrzypczak-Jankun E; Zhou K; Jankun J Int J Mol Med; 2003 Oct; 12(4):415-20. PubMed ID: 12964012 [TBL] [Abstract][Full Text] [Related]
34. Antiproliferative and apoptosis-inducing activities of alkyl gallate and gallamide derivatives related to (-)-epigallocatechin gallate. Dodo K; Minato T; Noguchi-Yachide T; Suganuma M; Hashimoto Y Bioorg Med Chem; 2008 Sep; 16(17):7975-82. PubMed ID: 18693020 [TBL] [Abstract][Full Text] [Related]
35. Kinetic study of the thermal stability of tea catechins in aqueous systems using a microwave reactor. Wang R; Zhou W; Wen RA J Agric Food Chem; 2006 Aug; 54(16):5924-32. PubMed ID: 16881696 [TBL] [Abstract][Full Text] [Related]
36. Biophysical Approach to Mechanisms of Cancer Prevention and Treatment with Green Tea Catechins. Suganuma M; Takahashi A; Watanabe T; Iida K; Matsuzaki T; Yoshikawa HY; Fujiki H Molecules; 2016 Nov; 21(11):. PubMed ID: 27869750 [TBL] [Abstract][Full Text] [Related]
37. Interactions between milk fat globules and green tea catechins. Rashidinejad A; Birch EJ; Everett DW Food Chem; 2016 May; 199():347-55. PubMed ID: 26775981 [TBL] [Abstract][Full Text] [Related]
38. Green and black tea are equally potent stimuli of NO production and vasodilation: new insights into tea ingredients involved. Lorenz M; Urban J; Engelhardt U; Baumann G; Stangl K; Stangl V Basic Res Cardiol; 2009 Jan; 104(1):100-10. PubMed ID: 19101751 [TBL] [Abstract][Full Text] [Related]
39. Interaction of tea catechins with lipid bilayers investigated by a quartz-crystal microbalance analysis. Kamihira M; Nakazawa H; Kira A; Mizutani Y; Nakamura M; Nakayama T Biosci Biotechnol Biochem; 2008 May; 72(5):1372-5. PubMed ID: 18460795 [TBL] [Abstract][Full Text] [Related]
40. Activation of the hTAS2R14 human bitter-taste receptor by (-)-epigallocatechin gallate and (-)-epicatechin gallate. Yamazaki T; Narukawa M; Mochizuki M; Misaka T; Watanabe T Biosci Biotechnol Biochem; 2013; 77(9):1981-3. PubMed ID: 24018685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]